SEER Seer (SEER) Insider Trading, Ownership & Congress Trades
Medical Devices · Laboratory analytical instruments · CIK 0001726445
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
23
13F, latest reported quarter
What the filings say about SEER
Insiders, 180 days
-$50.4K net sold
2 sellers · 0% of sales under a 10b5-1 plan
Seer insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Seer, Inc. insiders sold a net $50.4K of stock across 57 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 26 earlier Form 4 trades (code P or S) here by this insider (26 sales), the last on May 20, 2026.
- The trade is 1.5% of the 486,650 shares held after it.
- No other insider sold within 30 days.
- 23 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: PRESIDENT & CFO Horn David R. sold about $14.8K of SEER on Aug 18, 2026; 23 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jun 13, 2025.
- The trade is 18.1% of the 59,044 shares held after it.
- No other insider sold within 30 days.
- 23 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Nishar Dipchand sold about $23.3K of SEER on Jul 8, 2026; 23 funds added in the latest 13F quarter.Context
- 25 earlier Form 4 trades (code P or S) here by this insider (25 sales), the last on Feb 18, 2026.
- The trade is 1.5% of the 493,959 shares held after it.
- No other insider sold within 30 days.
- 23 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: PRESIDENT & CFO Horn David R. sold about $12.3K of SEER on May 20, 2026; 23 funds added in the latest 13F quarter.Context
- 24 earlier Form 4 trades (code P or S) here by this insider (24 sales), the last on Nov 19, 2025.
- The trade is 1.5% of the 501,262 shares held after it.
- 1 other insider sold within 30 days.
- 23 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: PRESIDENT & CFO Horn David R. sold about $15.4K of SEER on Feb 18, 2026; 1 other insider sold within 30 days and 23 funds added in the latest 13F quarter.Context
- 9 earlier Form 4 trades (code P or S) here by this insider (1 buy, 8 sales), the last on Nov 19, 2025.
- The trade is 0.7% of the 3,349,064 shares held after it.
- 1 other insider sold within 30 days.
- 23 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO AND CHAIR Farokhzad Omid sold about $48.5K of SEER on Feb 18, 2026; 1 other insider sold within 30 days and 23 funds added in the latest 13F quarter.57 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$50.4K over 180 days
-$14.8K over 90 days
more than 57% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
23 funds bought in last quarter
below 70% of Medical Devices
Revenue
+17.0% year over year
more than 67% of Medical Devices
Margin
-444.0% net margin
below 92% of Medical Devices
Buybacks
no share repurchases reported
Short interest
0.2% of the float short (float per yahoo 2026-10-27) · 1.0 days to cover · settled 2026-10-15
below 84% of Medical Devices
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch SEER
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-11.1%12M
Insider sell13D/G stakeForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns SEER: institutional holders (13F)
13F holdings, latest reported quarter
5,135,383 sh
$8.5M
2,458,673 sh
$4.1M
1,831,058 sh
$3.0M
1,428,405 sh
$2.4M
985,500 sh
$1.6M
Congress trades in SEER
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
13D: intends to influence · 13G: passive
Radoff Family Foundation
Activist 13D · 2026-02-20
0.9%
Radoff Bradley Louis
Activist 13D · 2026-02-20
3.7%
JEC II Associates, LLC
Activist 13D · 2026-02-20
1.9%
The MOS Trust
Activist 13D · 2026-02-20
0.4%
MOS PTC, LLC
Activist 13D · 2026-02-20
0.4%
SEER planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
DIPCHAND NISHAR
Filed 2026-07-08
$23.3K
SEER mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Ultra-Small Company Fund
$630.9K position · as of 2026-06-30
0.6%
Ultra-Small Company Market Fund
$110.7K position · as of 2026-06-30
0.1%
iShares Micro-Cap ETF
$257.7K position · as of 2026-06-30
0.0%
BlackRock Advantage Small Cap Core Fund
$568.3K position · as of 2026-05-29
0.0%
1290 VT Micro Cap Portfolio
$17.4K position · as of 2026-06-30
0.0%
Avantis U.S. Small Cap Equity ETF
$115.1K position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$3.5M
$4.6M
$1.1M
-90%
n/a
2023
$5.2M
-$136.7K
$1.4M
-91%
n/a
2022
$6.7M
-$15.5M
$3.9M
-75%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $50.4K sold by insiders over 180 days, 23 funds added last quarter. Each figure is a federal filing, dated the day it went public.
SEER financials
Revenue growth
+17.0%
XBRL, annual
Net margin
-444.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$14.2M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM SEER
| FY Dec 2025 | $16.6M |
| FY Dec 2024 | $14.2M |
| FY Dec 2023 | $16.7M |
| FY Dec 2022 | $15.5M |
| FY Dec 2021 | $6.6M |
| Jun 2026 | $3.1M |
| Mar 2026 | $2.8M |
| Dec 2025 | $4.2M |
| Sep 2025 | $4.1M |
| Jun 2025 | $4.1M |
| Mar 2025 | $4.2M |
| Dec 2024 | $4.0M |
| Sep 2024 | $4.0M |
At each fiscal year end
Single quarter
Net margin, TTM
-478.0%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM SEER
| FY Dec 2025 | -444.0% |
| FY Dec 2024 | -611.1% |
| FY Dec 2023 | -517.8% |
| FY Dec 2022 | -600.1% |
| FY Dec 2021 | -1,076% |
| Jun 2026 | -544.8% |
| Mar 2026 | -602.8% |
| Dec 2025 | -380.7% |
| Sep 2025 | -442.5% |
| Jun 2025 | -479.5% |
| Mar 2025 | -474.4% |
| Dec 2024 | -543.5% |
| Sep 2024 | -529.0% |
At each fiscal year end
Single quarter
Free cash flow, TTM
-$44.2M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM SEER
| FY Dec 2025 | -$46.2M |
| FY Dec 2024 | -$49.7M |
| FY Dec 2023 | -$66.4M |
| FY Dec 2022 | -$71.0M |
| FY Dec 2021 | -$53.3M |
| Jun 2026 | -$9.6M |
| Mar 2026 | -$15.7M |
| Dec 2025 | -$11.1M |
| Sep 2025 | -$7.8M |
| Jun 2025 | -$15.2M |
| Mar 2025 | -$12.1M |
| Dec 2024 | -$10.9M |
| Sep 2024 | -$16.3M |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity SEER
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt SEER
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-26.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity SEER
| FY Dec 2025 | -25.1% |
| FY Dec 2024 | -23.9% |
| FY Dec 2023 | -20.4% |
| FY Dec 2022 | -19.6% |
| FY Dec 2021 | -15.2% |
| Jun 2026 | -26.4% |
| Mar 2026 | -25.5% |
| Dec 2025 | -25.1% |
| Sep 2025 | -25.7% |
| Jun 2025 | -25.3% |
| Mar 2025 | -24.7% |
| Dec 2024 | -23.9% |
| Sep 2024 | -22.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-23.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets SEER
| FY Dec 2025 | -22.2% |
| FY Dec 2024 | -21.6% |
| FY Dec 2023 | -18.7% |
| FY Dec 2022 | -18.1% |
| FY Dec 2021 | -14.5% |
| Jun 2026 | -23.5% |
| Mar 2026 | -22.8% |
| Dec 2025 | -22.2% |
| Sep 2025 | -22.9% |
| Jun 2025 | -22.6% |
| Mar 2025 | -22.3% |
| Dec 2024 | -21.6% |
| Sep 2024 | -20.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital SEER
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-25.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed SEER
| FY Dec 2025 | -24.7% |
| FY Dec 2024 | -25.9% |
| FY Dec 2023 | -23.0% |
| FY Dec 2022 | -19.4% |
| FY Dec 2021 | -14.9% |
| Jun 2026 | -25.5% |
| Mar 2026 | -25.0% |
| Dec 2025 | -24.7% |
| Sep 2025 | -25.4% |
| Jun 2025 | -25.4% |
| Mar 2025 | -25.7% |
| Dec 2024 | -25.9% |
| Sep 2024 | -24.7% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing SEER
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value SEER
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-41.4%
TTM free cash flow over market value at close 2026-10-26
FCF yield SEER
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | -48.5% |
| Mar 2026 | -52.6% |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing SEER
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $16.6M | $14.2M | $16.7M | $15.5M |
| Gross profit | $8.5M | $7.1M | $8.5M | $7.1M |
| Operating income | -$78.0M | -$100.1M | -$103.5M | -$97.2M |
| Net income | -$73.6M | -$86.6M | -$86.3M | -$93.0M |
| EPS (diluted) | n/a | n/a | -1.35 | -1.49 |
| Operating cash flow | -$44.4M | -$46.1M | -$59.1M | -$60.8M |
| Cash | $47.3M | $40.8M | $32.5M | $53.2M |
| Buybacks | n/a | $0 | $13.0K | $20.0K |
SEC XBRL, fiscal years, as known on 2026-10-28
SEER Stock Sonar score 5/7 axes
Find similar shapesCompareSEER ranks highest on risk and compliance (84th percentile) and growth (67th), and lowest on insider conviction (28th), among Medical Devices peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SEER filings, in plain words
Are Seer insiders buying or selling SEER?
In the 180 days to 2026-10-28, Seer insiders were net sellers, a net $50.4K across purchases and sales reported on Form 4, by 2 sellers.
Read the full summary
In the 180 days to 2026-10-28, Seer insiders were net sellers of SEER, a net $50.4K across purchases and sales reported on Form 4 by 2 sellers. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. The latest 5% ownership filing is a 13D by Radoff Family Foundation, filed 2026-02-20, for 0.9% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
